Baba M Musa1, Musa A Garbati2, Ibrahim M Nashabaru3, Shehu M Yusuf3, Aisha M Nalado3, Daiyabu A Ibrahim3, Melynda N Simmons4, Muktar H Aliyu4. 1. Department of Medicine, Bayero University & Aminu Kano Teaching Hospital, Kano, Nigeria babamaiyaki2000@yahoo.co.uk. 2. Section of Infectious Diseases, King Fahad Medical City 11525 Riyadh, Saudi Arabia. 3. Department of Medicine, Bayero University & Aminu Kano Teaching Hospital, Kano, Nigeria. 4. Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract
BACKGROUND: There are conflicting reports of sex differences in HIV treatment outcomes in Africa. We investigated sex disparities in treatment outcomes for adults on first line antiretroviral treatment (ART) in Nigeria. METHODS: We compared clinical and immunologic responses to ART between HIV-infected men (n=205) and women (n=140) enrolled in an ART program between June 2004 and December 2007, with follow-up through June 2014. We employed Kaplan-Meier estimates to examine differences in time to immunologic failure and loss to follow-up (LTFU), and generalized estimating equations to assess changes in CD4+ count by sex. RESULTS: Men had lower baseline mean CD4+ count compared to women (327.6 cells/µL vs 413.4, respectively, p<0.01). Women had significantly higher rates of increase in CD4+ count than men, even after adjusting for confounders, p<0.0001. There was no significant difference in LTFU by sex: LTFU rate was 2.47/1000 person-months (95% CI 1.6-3.9) in the first five years for men vs 1.98/1000 person-months (95% CI (1.3-3.0) for women. There was no difference in time to LTFU by sex over the study period. CONCLUSIONS: Women achieved better long-term immune response to ART at baseline and during treatment, but had similar rates of long-term retention in care to men. Targeted efforts are needed to improve immune outcomes in men in our setting.
BACKGROUND: There are conflicting reports of sex differences in HIV treatment outcomes in Africa. We investigated sex disparities in treatment outcomes for adults on first line antiretroviral treatment (ART) in Nigeria. METHODS: We compared clinical and immunologic responses to ART between HIV-infectedmen (n=205) and women (n=140) enrolled in an ART program between June 2004 and December 2007, with follow-up through June 2014. We employed Kaplan-Meier estimates to examine differences in time to immunologic failure and loss to follow-up (LTFU), and generalized estimating equations to assess changes in CD4+ count by sex. RESULTS:Men had lower baseline mean CD4+ count compared to women (327.6 cells/µL vs 413.4, respectively, p<0.01). Women had significantly higher rates of increase in CD4+ count than men, even after adjusting for confounders, p<0.0001. There was no significant difference in LTFU by sex: LTFU rate was 2.47/1000 person-months (95% CI 1.6-3.9) in the first five years for men vs 1.98/1000 person-months (95% CI (1.3-3.0) for women. There was no difference in time to LTFU by sex over the study period. CONCLUSIONS:Women achieved better long-term immune response to ART at baseline and during treatment, but had similar rates of long-term retention in care to men. Targeted efforts are needed to improve immune outcomes in men in our setting.
Authors: Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews Journal: J Acquir Immune Defic Syndr Date: 2005-01-01 Impact factor: 3.731
Authors: Claudia Hawkins; Guerino Chalamilla; James Okuma; Donna Spiegelman; Ellen Hertzmark; Eric Aris; Tarcila Ewald; Ferdinand Mugusi; Deo Mtasiwa; Wafaie Fawzi Journal: AIDS Date: 2011-06-01 Impact factor: 4.177
Authors: James G Carlucci; Aniset Kamanga; Robb Sheneberger; Bryan E Shepherd; Cathy A Jenkins; John Spurrier; Sten H Vermund Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: Solomon Chih-Cheng Chen; Joseph Kwong-Leung Yu; Anthony David Harries; Chin-Nam Bong; Rose Kolola-Dzimadzi; Teck-Siang Tok; Chwan-Chuen King; Jung-Der Wang Journal: Trop Med Int Health Date: 2008-02-14 Impact factor: 2.622
Authors: Sabina F Mugusi; Julius C Mwita; Joel M Francis; Said Aboud; Muhammad Bakari; Eric A Aris; Andrew B Swai; Ferdinand M Mugusi; Kisali Pallangyo; Eric Sandstrom Journal: BMC Public Health Date: 2010-05-28 Impact factor: 3.295
Authors: Arif Alibhai; Walter Kipp; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Stan Houston; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale Journal: Int J Womens Health Date: 2010-08-09
Authors: Maureen H Rumptz; Carol Tobias; Serena Rajabiun; Judith Bradford; Howard Cabral; Robin Young; William E Cunningham Journal: AIDS Patient Care STDS Date: 2007 Impact factor: 5.078
Authors: Monica Gandhi; Peter Bacchetti; Paolo Miotti; Thomas C Quinn; Fulvia Veronese; Ruth M Greenblatt Journal: Clin Infect Dis Date: 2002-07-02 Impact factor: 9.079
Authors: C V Loupa; B Rodriguez; G McComsey; B Gripshover; R A Salata; H Valdez; M V Lisgaris; S A Fulton; M M Lederman Journal: Clin Microbiol Infect Date: 2006-04 Impact factor: 8.067
Authors: Natalie Jean Tibbels; Zoé Mistrale Hendrickson; Danielle Amani Naugle; Abdul Dosso; Lynn Van Lith; Elizabeth C Mallalieu; Anne Marie Kouadio; Walter Kra; Diarra Kamara; Patricia Dailly-Ajavon; Adama Cisse; Kim Seifert-Ahanda; Sereen Thaddeus; Stella Babalola; Christopher J Hoffmann Journal: PLoS One Date: 2019-03-21 Impact factor: 3.240